September 12, 2014 — The first researcher in the world to discover that aspirin prevents a first attack, Charles H ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
September 12, 2014
September 3, 2014 –In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable ...
September 03, 2014
September 2, 2014 – Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare ...
September 02, 2014
August 28, 2014 — The American College of Cardiology and the American Heart Association today released a revised ...
August 28, 2014August 25, 2014 — New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with ...
August 25, 2014
August 20, 2014 — AstraZeneca received confirmation from the United States Department of Justice that it is closing its ...
August 20, 2014August 5, 2014 — The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary ...
August 05, 2014
August 1, 2014 — Researchers at Wayne State University have made a fundamental discovery and, in subsequent ...
August 01, 2014July 30, 2014 — Regado Biosciences announced earlier this month it has voluntarily paused enrollment in its REGULATE-PCI ...
July 30, 2014
Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. In fact, at ...
July 23, 2014
July 17, 2014 — A clinical study by researchers at CVS Caremark, Aetna and Brigham and Women’s Hospital published in the ...
July 17, 2014July 2, 2014 — LipoScience Inc. announced the publication of the first large-scale real world study evidencing a link ...
July 02, 2014June 25, 2014 — The U.S. Food and Drug Administration (FDA) has completed its safety review and has found no clear ...
June 26, 2014June 20, 2014 — Less aggressive anticoagulation therapy, combined with low-dose aspirin, can be used safely in ...
June 20, 2014June 17, 2014 — AtheroNova Inc. received a Notice of Issuance for an additional compound for cardiovascular treatments ...
June 17, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now